Charles N. Serhan, Tomoko Takano, Karsten Gronert, Nan Chiang, Clary B. Clish
Lipoxin and Aspirin-Triggered 15-epi-Lipoxin Cellular Interactions Anti-Inflammatory Lipid Mediators
Eicosanoids are known to play important roles in inflammation.
Recent findings have given rise to several
new concepts regulating the generation of eicosanoids,
illustrated in Figure 1. Lipoxins (LX) are trihydroxytetraene-containing eicosanoids that are generated
within vascular lumen by platelet-leukocyte
interactions and at mucosal surfaces by leukocyte-epithelial
cell interactions. During these cell-cell interactions,
transcellular biosynthetic pathways are used as
major routes, and thus, in humans, LX are formed in
vivo during multicellular responses such as inflammation,
atherosclerosis, and thrombosis. This branch of
the eicosanoid cascade generates specific tetraene-containing
products that appear to function as stop
signals, since they inhibit key steps in leukocyte-mediated
inflammation. Of special interest, it appears that
aspirin also functions in part via production of novel
epimers of lipoxins or 15-epi-lipoxins (Figure 1). Here,
we review recent developments on the cellular interactions
of these novel anti-inflammatory mediators.
Clinical Chemical Laboratory Medicine, Walter de Gruyter
Print ISSN: 1434-6621
Volume: 37, 03/1999
Pages: 299 - 309
Show full article (external site)
Show all available items of this journal